Articles by Chris Donaldson - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Chris Donaldson

Formulation Studies of an Adsorbed Conjugate Vaccine

How a thorough formulation study ensured the development of a stable and effective vaccine.
Oct 2, 2008

NeisVac-C is a polysaccharide-protein conjugate vaccine for use against Neisseria meningitidis serogroup C infection. The Phase 1 clinical formulation consisted of physiological saline, thimerosal, and aluminum hydroxide. The long-term stability data for both the PBS and saline formulations are presented in this article.

ADVERTISEMENT

ADVERTISEMENT

Click here